Dynamic Microsteppers Limited Sets November 14 Q2 FY27 Board Meet
Key highlights
- Dynamic Microsteppers Limited will hold its Q2 FY27 results board meeting on November 14, 2026.
- The board will consider unaudited results for the quarter and half-year ended September 30, 2026.
- Dynamic Microsteppers reported a June 2026 quarter net loss of ₹9 lakh with nil sales.
- FY26 revenue from operations was ₹0, while net loss widened to ₹26.9 lakh from ₹16.4 lakh in FY25.
powered by IRIS

Dynamic Microsteppers Limited will hold a board meeting on November 14, 2026, to consider unaudited financial results for Q2 FY27 and the half-year ended September 30, 2026. The meeting matters because the company’s latest reported annual and quarterly disclosures showed no revenue from operations and continued net losses.
Know Dynamic Microsteppers inside out
Results, valuation, peers and who's buying, in one view.
When will Dynamic Microsteppers Limited consider Q2 FY27 results?
Dynamic Microsteppers Limited will consider, approve and take on record its unaudited financial results for the quarter and half-year ended September 30, 2026, at a board meeting scheduled for Saturday, November 14, 2026. The company is listed on the BSE under the code 531330.
The agenda also includes consideration of the limited review report on the financial statements. Such reports are issued in connection with quarterly unaudited results and form part of the company’s financial disclosure process. The board may also discuss other company matters, according to the meeting notice.
The September quarter is the second quarter of FY27, while the half-year results will cover the six months from April 1, 2026, to September 30, 2026. The forthcoming filing will provide the next formal update on the company’s operating performance after its June 2026 quarter results.
What is the insider trading window restriction for the results?
Dynamic Microsteppers has said the trading window for designated persons will remain closed until 48 hours after publication of the unaudited results. The restriction applies around the disclosure of financial information that could be material for trading decisions.
The stated closure period is linked to the November 14 board meeting and the subsequent release of the results. The source does not specify the date from which the trading window was closed, but it confirms that reopening will occur only after the prescribed 48-hour period following publication.
The trading-window measure is part of the company’s compliance process for handling unpublished price-sensitive information. Investors should distinguish this procedural restriction from an operational update, as the announcement does not disclose Q2 FY27 revenue, expenses, profit or loss figures ahead of the board meeting.
What do previous Dynamic Microsteppers results show?
Dynamic Microsteppers reported no sales in the quarter ended June 2026 and a standalone net loss of ₹9 lakh, compared with a net loss of ₹12 lakh in the quarter ended June 2025. The June-quarter figures are the latest quarterly performance data available in the supplied information.
For FY26, the company reported zero revenue from operations and a net loss of ₹26.9 lakh, compared with a loss of ₹16.4 lakh in FY25. The company said it did not carry out business activities during FY26. Higher total expenses of ₹26.9 lakh, against ₹16.4 lakh in the prior year, accounted for the wider annual loss.
The company’s basic loss per share for FY26 was ₹0.78, compared with a loss per share of ₹0.48 in FY25. Earlier reported quarterly data also showed no sales for the March 2026 and December 2025 quarters, alongside standalone net losses of ₹7 lakh and ₹4 lakh, respectively.
Got a follow-up? Ask IRIS
Why does the November 14 meeting matter to investors?
The November 14 meeting matters because it will establish whether the no-revenue position disclosed in recent periods continued through the September 2026 quarter and the first half of FY27. It will also show the level of expenses and the resulting profit or loss for both periods.
The available financial record points to a company that remained operationally inactive in FY26. In this context, quarterly result disclosures are particularly relevant for assessing any change in reported sales, operating activity, costs, or earnings per share. No such change has been announced in the board-meeting notice.
The September-quarter filing should also allow investors to compare the six-month FY27 loss with the disclosed June-quarter loss of ₹9 lakh. However, no forecast or estimate for the upcoming quarter has been provided. Any assessment of financial progress will therefore depend on the unaudited figures and limited review report released after the board’s consideration.
There is no share-price movement, trading volume data, or analyst commentary in the supplied information. As a result, the disclosed market relevance is limited to the scheduled financial update and the applicable trading-window closure, rather than any stated immediate reaction from investors or the broader market.
What is the recent corporate background of Dynamic Microsteppers?
Dynamic Microsteppers’ shareholders approved all three resolutions at the company’s 41st Annual General Meeting held on September 30, 2026, with 100% votes in favour. The meeting adopted the FY26 financial statements and confirmed director appointments.
The FY26 accounts provided the most detailed recent indication of the company’s financial position in the supplied disclosures. With no revenue from operations, the reported expenses flowed directly into the annual loss. This makes the forthcoming Q2 and half-year filing important as an updated record of whether revenue and operating activity remained absent or changed.
The company has also followed a recurring schedule of board meetings for periodic financial results. For example, it informed the BSE of a board meeting on August 13, 2025, to consider June 2025 quarter results, and a meeting on February 14, 2025, that approved results for the quarter and nine months ended December 31, 2024.
Conclusion
Dynamic Microsteppers has scheduled its November 14, 2026 board meeting to approve unaudited Q2 FY27 and first-half FY27 results, along with considering the related limited review report. The scheduled disclosure is significant against the company’s recent history of nil revenue, including FY26, and reported net losses in its latest available annual and June-quarter results.
Investors should watch for the figures for revenue from operations, total expenses, net profit or loss, and earnings per share for the quarter and half-year ended September 30, 2026. The results publication, followed by the 48-hour trading-window restriction, is the next disclosed event in the company’s financial reporting calendar.


